C50 C61
Conditions
Interventions
Group 1: Patients with breast or prostate cancer will be examined at the time of diagnosis or before medical cancer treatment (T0), at the beginning (T1) and at the end (T2) of inpatient rehabilitatio
Sponsors
Technische Universität ChemnitzFakultät für Human- und SozialwissenschaftenInstitut für Angewandte BewegungswissenschaftenProfessur für Sportmedizin/-biologie
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patient age 20-75 years, Female patients with initial diagnosis: Breast cancer (ICD C50), Male patients with initial diagnosis: Prostate cancer (ICD C61), Willingness to participate in study
Exclusion criteria
Exclusion criteria: Patient age 75 years, Medically diagnosed severe cognitive impairment (Dementia, M. Parkinson, M. Alzheimer), Other malignant tumors, Organic and / or inflammatory Disorders which are incompatible with the tests (in particular: acute coronary syndrome, stable stage II angina pectoris after CCS, unchecked arterial hypertension, NYHA stage II heart failure, GOLD stage II COPD, stage II peripheral vascular disease) to Fontaine)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Five examination times (T0-T4) Objective criteria: 1. BIA: phase angle 2. Reaction test: reaction time 3. DSNT test: latency, distance, time 4. Purdue Pegboard test: number of pins, number of assembly units 5. Handgrip strength 6. 6-minute-walk-distance 7. Questionnaire scores (HADS-D, FACIT-Fatigue, FACT-Cog, FACT-B/P/G) | — |
Countries
Germany
Contacts
Public ContactAlexander Stäuber
Technische Universität ChemnitzFakultät für Human- und SozialwissenschaftenInstitut für Angewandte BewegungswissenschaftenProfessur für Sportmedizin/-biologie
Outcome results
None listed